department

Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access

therapeutic area

Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease

location & type

Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →

when

Latest
Archive

by source

All Sources
Sources Page

by activity

Most Active
Biggest Pipelines
Recently Active

hiring

Companies Hiring Now
Big Pharma Roles
All Companies →

Drugs & Pipeline

intelligence

Drugs
Patent Cliff

research

Publications
Topics

window

Next 90 Days
All (incl. Past)

by type

PDUFAs
Approvals
Earnings
Readouts

Sign In Subscribe

pharmadog

fetch the data · sniff the signal

Discover

Calendar
Drugs
Companies
News

Hubs

Topics
Jobs
Patent cliff
Publications

Tools

Compare
Search
Bookmarks

Trust

About
Sources
Contact

Legal

Privacy
Terms
Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

home
jobs
news
cal
search

METHOTREXATE · pharmadog

pharmadog
drugs
METHOTREXATE

drug · small molecule

patient view →

METHOTREXATE

Phase 2updated 2mo ago

by $ALDX Aldeyra Therapeutics, Inc.🔗 ChEMBL

Phase 2

community read0 votes

Small molecule drug with a maximum clinical stage of Approval (across all indications), with 15 approved and 79 investigational indications.

targets

Dihydrofolate reductase

all catalysts(0)

nothing on the calendar yet

News(0)

no news has mentioned this drug yet

brand

METHOTREXATE

trade names

Ebetrex, Emtexate high-pot, Emtexate pf, Jylamvo, Maxtrex, Metoject

generic

METHOTREXATE

MOA

Dihydrofolate reductase inhibitor

indication

Retinitis Pigmentosa (Retinitis)

phase

phase_2

Data sources

ClinicalTrials.gov · OpenTargets

last refreshed 2h ago

Found something off?

🐶 something off?

Report a data issue

Tell Bork what looks wrong — wrong sponsor, stale phase, mislinked ticker, anything. We’ll triage and fix.

comments(0)

5-min edit window · permanent after that

sign in to leave a comment · permanent archive after 5 minutes

no comments yet — first sniff?

🐶 often sniffed alongside

top 8

tagApproval40 co-mentions · 13 sources
drugMaxtrex39 co-mentions · 18 sources
drugMethotrexate Intas39 co-mentions · 18 sources
drugMethotrexate Teva39 co-mentions · 18 sources
drugMETHOTREXATE SODIUM32 co-mentions · 11 sources
tagOncology4 co-mentions · 2 sources
tagDrug Shortage3 co-mentions · 3 sources
companyCity of Hope1 co-mentions · 1 sources

Trials studying METHOTREXATE

phase2Eflornithine (DFMO) for Ewing Sarcoma and Osteosarcomarecruitingn=406
phase2A Study to Investigate the Clinical Effect and the Safety of PRX-115 Infused Intravenously at Different Dosing Regimens, With and Without Methotrexate, Versus Placebo in Adults Gout Patients (RELEASE)recruitingn=150
phase2A Study of the Efficacy and Safety of Lisocabtagene Maraleucel (Liso-cel) as First-Line Therapy in Adults With Transplant-Ineligible Primary Central Nervous System Lymphomarecruitingn=65
phase1Venetoclax, Dasatinib, Prednisone, Rituximab and Blinatumomab for the Treatment of Newly Diagnosed or Relapsed Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia or Mixed Phenotype Acute Leukemiaactive not recruitingn=20
phase1A Trial to Examine the Interaction of Repinatrabit With Ethinyl Estradiol/Norethindrone, Metformin,Carbamazepine, Rosuvastatin, and Methotrexate When Administered Togetherrecruitingn=48
phase2A Clinical Study of Tulisokibart (MK-7240) to Treat Rheumatoid Arthritis (RA) (MK-7240-014)recruitingn=182
phase1P-BCMA-ALLO1 Allogeneic CAR-T Cells in the Treatment of Subjects With Multiple Myelomaactive not recruitingn=275
phase3Perioperative Durvalumab With Neoadjuvant ddMVAC or Gemcitabine/Cisplatin in Patients With Muscle-invasive Bladder Cancer (NIAGARA-2)recruitingn=150

more trials →